Hemp Hull Compounds Show Promise for Gut Barrier Support in Cell-Based Research
Cell-based study hints hemp hull compounds NCT and NFT may support gut barrier health, but human benefits remain unproven; more research is needed.
Cell-based study hints hemp hull compounds NCT and NFT may support gut barrier health, but human benefits remain unproven; more research is needed.
Discover what the science says about cannabis and amyloidosis: no proven disease-fighting benefits, possible symptom relief, and why expert care matters.
CBD shows preclinical promise for skin damage but cannot treat xeroderma pigmentosum; more clinical research is needed and UV protection remains essential.
"Cannabis is not an established treatment for alcohol use disorder; explore the latest cautious research on CBD/THC, potential craving effects, and safety."
What does the evidence say about cannabis for spinal stenosis pain? It may help neuropathic pain but does not reverse narrowing or treat underlying condition.
Can medical cannabis help lymphoma patients manage chemo-induced nausea? Learn what current guidelines say and why it's a supportive care option, not a cure.
A Johns Hopkins trial suggests high-dose CBD may boost the effects of edible THC, raising safety questions and challenging the entourage effect claim.
What the science really says about THC-O and THCP: do potency claims hold up, what are safety risks, and how legality actually works.
New corrected analysis finds no rise in teen cannabis use after legalization; what policymakers and parents should know about myths and real-world effects.
New research shows CBD may slow nicotine breakdown by inhibiting enzymes like CYP2A6 but it's early lab data and not a proven quit-smoking aid.